Pharmacogenomics and cancer stem cells: a changing landscape?
- 31 August 2011
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 32 (8) , 487-494
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- BMI1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancerInternational Journal of Cancer, 2011
- Human prostate sphere‐forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivoThe Prostate, 2009
- HEY1 Leu94Met gene polymorphism dramatically modifies its biological functionsOncogene, 2009
- Human colon cancer epithelial cells harbour active HEDGEHOG‐GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansionEMBO Molecular Medicine, 2009
- Looking ahead in cancer stem cell researchNature Biotechnology, 2009
- Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapyBritish Journal of Cancer, 2008
- HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and TumorigenicityCurrent Biology, 2007
- Tumour stem cells and drug resistanceNature Reviews Cancer, 2005
- The Hallmarks of CancerCell, 2000
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997